Acumen Pharmaceuticals (ABOS) Insider Porter Sells 13,040 Shares
Derrell Porter sold 13,040 shares of ABOS on June 17, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Derrell Porter sold 13,040 shares of Acumen Pharmaceuticals, Inc. ($ABOS) on June 17, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $ABOS is up 2.7% after 1 week, up 0.0% after 1 month and down 24.9% to date (from the $2.25 close on Jun 17, 2026).
ABOS
Acumen Pharmaceuticals, Inc.
Key Points
- Derrell Porter sold 13,040 shares of ABOS on June 17, 2026, with no stated transaction value.
- ABOS shares traded at $2.33 at the time of the transaction, though the exact sale price was not disclosed.
- No additional insider transactions, analyst ratings, or institutional changes were reported for ABOS.
Get $ABOS trade alerts by text
We text you when insiders, Congress or big funds trade $ABOS. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Acumen Pharmaceuticals, Inc. alert may contain errors. Disclosures
On June 17, 2026, Derrell Porter sold 13,040 shares of ABOS. The transaction did not specify a sale price, but ABOS shares were trading at $2.33 at the time.
Insider Buying and Selling at Acumen Pharmaceuticals, Inc.
Derrell Porter was involved in a notable transaction involving ABOS, selling 13,040 shares. The sale did not occur under a pre-planned trading scheme, and the transaction code was recorded as 'M'.
Bottom Line
The decision by Derrell Porter to sell shares of ABOS is a point of interest for investors tracking insider activity. While the transaction did not specify a sale price, the stock traded at $2.33. Such insider transactions can provide insights into the sentiment of those closest to the company.
Related Filing Alerts
Source: Derrell Porter's Form 4 filing on $ABOS (Jun 17, 2026). Find the original filing: ABOS Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts